Non-coding RNAs: biological properties and ways of use

Authors

  • I. S. Khripkov SI «Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine», Dnipro, Ukraine, Ukraine https://orcid.org/0000-0003-0378-8414
  • A. G. Dudlya SI «Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine», Dnipro, Ukraine., Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2020.3.186-191

Keywords:

non-coding RNAs, types, biological properties, ways of use

Abstract

RNA - one of four main macromolecules of a cell therefore certainly is a subject of the numerous researches directed to definition of its role in metabolic processes of a cell with participation of molecular mechanisms. For many years was considered that the RNA main function consists in performance of a role of the intermediary in the course of reading of the amino-acid sequence from the coding gene. Therefore opening that the sequences coding protein are less than 2% of all genome became one of the greatest surprises in modern biology; in a consequence it was established that about 90% of human genome are actively transcribed. In the overview biological properties, a way of transportation and mechanisms of influence on a cell of non-coding RNA are discussed. Non-coding RNA perform important biological function in development of organisms, their physiology and pathology. In family of non-coding RNA allocate several RNA groups which differ in origin and degree of a homology to target mRNA, have properties to inactivate at the same time several various mRNA, are highly specific inhibitors of synthesis of protein. MicroRNA regulate activity of effector molecules and play a key role in regulation of a gene expression and modulation of process of broadcasting. Participation of microRNA in regulation of processes of differentiation, proliferation, apoptosis and reaction to a stress is proved. Under control of microRNA there can be at once several regulatory ways which are responsible for a certain condition of a cell therefore disturbance of an expression of microRNA leads to dysregulation of all alarm network and disturbance of functioning of a cell. It is established that disturbance of functioning of separate types of microRNA can cause tumoral transformation, development of neurologic pathology and different types of pathology of a cardiovascular system.

References

  1. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD, authors. Molecular biology of the cell. 3rd ed. New York: Garland Publishing; 1994. 1616 p.
  2. Lodish H, Berk A, Zipursky AL, Matsudaira P, Baltimore D, Darnell J, authors. Molecular cell biology. 4th ed. New York: W. H. Freeman; 2000. 897 p.
  3. Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO reports. 2001; 2(11): 986–91.
  4. Jiayan Wu, Jingfa Xiao, Zhang Zhang, Xumin Wang, Songnian Hu, Jun Yu. Ribogenomics: the Science and Knowledge of RNA. Genomics Proteomics Bioinformatics. 2014; 12: 57-63.
  5. Balashenko NA, Dromashko SE. Long non-coding RNAs and their functions. Proceedings of the National Academy of Sciences of Belarus. Biological series. 2017; 4: 110–19.
  6. Elbashir SM, Harborth J, Lendeckel W. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411(6836):494–8.
  7. Ohshima K., Inoue K., Fujiwara A. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010; 5(10): 132-47.
  8. Andreeva OE, Krasil’nikov MA. [The phenomenon of RNA interference in oncology: advances, problems and perspectives]. Advances in molecular oncology. 2016; 3:8-15. Russian.
  9. Mann DL. MicroRNAs and the failing heart. N. Engl. J. Med. 2007; 356: 2644-45.
  10. Fedorov AV, Kostareva AA, Galagudza M M. [Perspektivy ispol'zovaniya mikroRNK v kachestve biomarkera ishemicheskogo povrezhdeniya miokarda [MicroRNA as biomarkers of myocardial ischemic injury: a perspective.]. Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya [Regional Haemodynamics and Microcirculation], 2012; 11(3): 69-75.
  11. Kung JT, Colognori D, Lee JT. Long Noncoding RNAs: Past, Present, and Future. Genetics. 2013; 193(3): 651-69.
  12. Fire A, Xu S, Montgomery MK. Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis Elegans. Nature. 1998; 391:806–11.
  13. Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol J. 2011;6(9):1130–46.
  14. Angelbello AJ, Chen JL, Childs-Disney JL. Using Genome Sequence to Enable the Design of Medicines and Chemical Probes. Chem Rev. 2018 February 28; 118(4): 1599–1663.
  15. Lu J, Getz G, Miska EA. MicroRNA expression profiles classify human cancers. Nature, 2005; 435: 834-38.
  16. Xiao J, Yang B, Lin H. Novel approaches for genespecific interference via manipulating actions of microRNAs : examination on the pacemaker channel genes HCN2 and HCN4. J. Cell. Physiol. 2007; 212: 285-92.
  17. Ivkin DYu, Lisitskiy DS, Zakharov EA. [MicroRNA as perspective diagnostic and pharmacologic agents]. Astrahanskiy meditsinskiy jurnal. 2015; 2:8-25. Russian.
  18. Stenvang J. Inhibition of microRNA function by antimiR oligonucleotides. Silence. 2012; 3: 1-17.
  19. Patrushev MV, Kamenski PA, Mazunin IO. Mutations in mitochondrial DNA and approaches for their correction. Biochemistry (Mosk.). 2014; 79(11): 1151—60.
  20. Kolesnikova OA, Entelis NS, Jacquin-Becker C. Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells. Hum. Mol. Genet. 2004; 13(20): 2519-34.
  21. Kolesnikova OA, Entelis NS, Mireau H. Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm. Science. 2000;.289(5486): 1931—33.
  22. Karicheva OZ, Kolesnikova OA, Schirtz T. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria. Nucleic Acids Res. 2011; 39(18): 8173—86.
  23. Lakunina VA, Baleva VS, Levitskii SA. [RNA import into mitochondria and its use in the gene therapy]. Vestnik Moskovskogo universiteta. Seriâ 16, Biologiâ, 2015; 3:32-6. Russian.
  24. Alexis F, Pridgen E, Molnar LK. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008; 5(4):505–15.
  25. Lu D, Benjamin R, Kim M. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther. 1994; 1:245–52.
  26. Glenn, JS, Ellens H, White JM. Delivery of liposome-encapsulated RNA to cells expressing influenza virus hemagglutinin. Methods Enzymol. 1993; 221:327–39.
  27. Malone RW, Felgner PL, Verma IM. Cationic liposomemediated RNA transfection. Proc. Natl. Acad. Sci. USA. 1989; 86:6077–81.
  28. Haque ME, McIntosh TJ, Lentz BR. Influence of lipid composition on physical properties and peg-mediated fusion of curved and uncurved model membrane vesicles “Nature’s own” fusogenic lipid bilayer. Biochemistry 2001;40(14):4340–8.
  29. Rider MA, Hurwitz SN, Meckes DG. ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Sci. Rep. 2016; 6:239-78.
  30. Love KT, Mahon KP, Levins CG. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. USA. 2010;107(5):1864–9.
  31. Lee H, Lytton-Jean AK, Chen Y. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 2012; 7(6):389–93.
  32. Semple SC, Akinc A, Chen J. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 2010; 28(2):172–6.
  33. Probst J, Weide B, Scheel B. Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cell Mol. Life Sci. 2004; 61:2418-24.
  34. Conry RM, LoBuglio AF, Wright M. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 1995; 55:1397-400.
  35. Hoerr I, Obst R, Rammensee HG, Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol 2000; 30:1-7.
  36. Lorenz C, Fotin-Mleczek M, Roth G. Protein expression from exogenous mRNA Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway. RNA Biolog. 2011; 8(4): 627-36.
  37. Boussif O, Lezoualc’h F, Zanta MA. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA. 1995; 92:7297-301.
  38. Lundberg P, El-Andaloussi S, Johansson H. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J. 2007; 21:2664-71.
  39. Cullis PR, Hope MJ, Tilcock CP. Lipid polymorphism and the roles of lipids in membranes. Chem. Phys. Lipids. 1986; 40:127-44.
  40. Farhood H, Serbina N, Huang L. The role of dioleoylphosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta. 1995; 1235:289-95.
  41. Sonawane ND, Szoka FC, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol Chem. 2003; 278:44826-31.
  42. Duane A. Mitchell, Smita K. Nair. RNA-transfected dendritic cells in cancer immunotherapy. J. Clin. Invest. 2000;106(9):1065-69.

Downloads

How to Cite

Khripkov, I. S., & Dudlya, A. G. (2020). Non-coding RNAs: biological properties and ways of use. Морфологія / Morphologia / Morfologìâ, 14(3), 186–191. https://doi.org/10.26641/1997-9665.2020.3.186-191

Issue

Vol. 14 No. 3 (2020)

Section

Статті

License

Copyright (c) 2020 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.